News from allergan A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 08, 2019, 18:05 ET Allergan 360° Aesthetics Report™ Reveals Evolving Beauty Perceptions And Diverse Priorities Around The World

Allergan plc (NYSE: AGN) today released the results of their first-of-its-kind worldwide medical aesthetics study, titled the Allergan 360°...


Jul 11, 2017, 08:07 ET See America Furthers The Fight Against Preventable Blindness With #EyePic Campaign

Allergan plc (NYSE: AGN), a global leader in eye care for nearly 70 years, today unveiled #EyePic, an exciting new online awareness campaign as part...


Mar 14, 2017, 09:10 ET Award Winning Actor And Hip-Hop Artist Common Joins Allergan's See America(SM) Initiative To Further The Fight Against Preventable Blindness

See America, Allergan's initiative to fight against preventable blindness in the United States, today unveiled a powerful video featuring...


May 04, 2016, 07:50 ET Allergan Presents Data at the 2016 American Society of Cataract and Refractive Surgery (ASCRS) Symposium & Congress in New Orleans

Allergan (NYSE: AGN) today announced that its data will be presented during the 2016 American Society of Cataract and Refractive Surgery (ASCRS)...


Apr 25, 2016, 04:05 ET Allergan Breaks Ground on $200 Million Waco Facility Expansion

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today broke ground on a $200 million expansion of its Waco, Texas facility. The...


Oct 06, 2015, 07:01 ET Allergan and Medicines360 Announces LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg IUS Presented in 3 Abstracts at FIGO 2015

Allergan plc (NYSE: AGN) and Medicines 360 today announced that LILETTA® will be featured in 3 abstracts presenting new data at the FIGO World...


Jul 15, 2015, 04:01 ET Allergan Notes Receipt of Paragraph IV Notification on Restasis

Allergan plc (NYSE: AGN) today confirmed that the Company has received a notice letter dated July 10, 2015 (the "Notice Letter") from Akorn...


Mar 02, 2015, 09:07 ET Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent

According to statistics released by the American Society of Plastic Surgeons (ASPS), the use of Hyaluronic Acid (HA) dermal fillers, such as the...


Nov 11, 2014, 01:37 ET New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX® Cosmetic (onabotulinumtoxinA)

Many women are familiar with the brand name BOTOX® Cosmetic (onabotulinumtoxinA), but a new study from SheSpeaks™, an online community of women,...


Aug 20, 2014, 08:30 ET Beauty School is In Session -- Create a No-Makeup, Makeup Look

Renowned beauty expert and makeup artist to the stars Julianne Kaye is partnering with Allergan, the makers of ACZONE® (dapsone) Gel 5%, the No. 1...


May 16, 2014, 08:30 ET The Urology Care Foundation and Allergan Promote Patient Education and Advocacy at the 2014 American Urological Association Meeting

The Urology Care Foundation, the world's leading nonprofit urological health foundation and official foundation of the American Urological...


Apr 22, 2013, 09:00 ET Reading Between the [Facial] Lines

When it comes to non-verbal communication, is your facial language leaving others lost in translation? TORONTO, April 22, 2013 /CNW/ - Ever been told ...


May 11, 2012, 14:19 ET BOTOX® (Botulinumtoxin Typ A von Allergan) empfohlen vom National Institute for Health and Clinical Excellence (NICE) zur Prävention von chronischer Migräne bei Patienten, bei denen bisherige Behandlungen versagt haben

Allergan hat heute bekanntgegeben, dass das National Institute for Health and Clinical Excellence (NICE) BOTOX® (Botulinumtoxin Typ A) zur Prophylaxe ...


Jun 05, 2011, 07:01 ET NICE Recommends OZURDEX(R), an Innovative Treatment for Retinal Vein Occulsion (RVO), a Common Cause of Vision Loss

Allergan announces today that the National Institute for Health and Clinical Excellence (NICE) has recommended OZURDEX(R) (dexamethasone 0.7mg...